Showing results (41-50 of 159) with videos related to

Sort By:
Pageof 16
Journal of Drugs in Dermatology : JDD|January 15, 2008
Duration of remission of biologic agents for chronic plaque psoriasisRichard G Langley, Kenneth B Gordon
Immunotherapy|November 14, 2022
Deucravacitinib in moderate-to-severe psoriasisAlan Vu, Victoria Maloney, Kenneth B Gordon
Seminars in Cutaneous Medicine and Surgery|May 1, 2010
Anti-p40 antibodies ustekinumab and briakinumab: blockade of interleukin-12 and interleukin-23 in the treatment of psoriasisMona Gandhi, Eihab Alwawi, Kenneth B Gordon
Immunotherapy|October 4, 2019
Risankizumab in moderate-to-severe plaque psoriasisLinda Serrano, Victoria Maloney, Kenneth B Gordon
Expert Opinion on Biological Therapy|October 15, 2022
Anti-IL 23 biologics for the treatment of plaque psoriasisAlan Vu, Caden Ulschmid, Kenneth B Gordon
Archives of Dermatology|May 22, 2002
Biologic therapy for psoriasis: the new therapeutic frontierPrashant Singri, Dennis P West, Kenneth B Gordon
American Journal of Clinical Dermatology|July 13, 2024
Sequencing of Targeted Therapy in Psoriasis: Does it Matter?Nicole D Boswell, Shikha Singla, Kenneth B Gordon
Pageof 16